Apellis Pharmaceuticals is the most overbought healthcare stock as Q1 earnings roll on
Source: SeekingAlpha
2026-04-20 11:55:48 ET
More on Health Care stocks
- IHI: Pullback Creates A Buying Opportunity In High-Growth MedTech
- Routine Vaccines Okay For Now: Investment Implications Of The Court Decision
- Sector Rotation: Healthcare XLV Should Be The Next Stop
- Cybin stands out as the most undervalued psychedelic stock as Trump signs on faster PTSD research
- Notable healthcare headlines for the week: J&J, Abbott and Organon in focus
Read the full article on Seeking Alpha
For further details see:
Apellis Pharmaceuticals is the most overbought healthcare stock as Q1 earnings roll on
Summit Therapeutics Inc.
NASDAQ: SMMT
SMMT Trading
-2.55% G/L:
$14.53 Last:
2,046,527 Volume:
$14.925 Open:
SMMT Latest News
June 04, 2026 04:30:00 pm
Summit Therapeutics to Participate in the 47th Annual Goldman Sachs Global Healthcare Conference
May 31, 2026 02:05:00 pm
This Emerging Risk Is Unlike Anything the Biotech Industry Has Ever Experienced
SMMT Stock Data
$11,408,581,895
112,410,823
0.02%
74
N/A
Biotechnology & Life Sciences
Healthcare
US
Miami
